Medtronic PLC

AI Summary

Medtronic manufactures and sells medical devices across four main areas: heart devices like pacemakers and heart valves, neuroscience products including spinal implants and brain stimulation systems, surgical tools including robotic-assisted surgery platforms, and diabetes management products like insulin pumps and glucose monitors [Company Overview]. The company serves hospitals, physicians, and patients in over 150 countries worldwide.

Medtronic is a major medical device company that makes cardiac devices, spinal implants, surgical tools, and diabetes management systems. The company faces moderate financial health concerns with slowing growth and operational inefficiencies [Yahoo Finance], but it maintains a 48-year dividend growth streak and is investing in AI-powered surgical robotics [Yahoo Finance]. Recent news highlights leadership changes in key divisions and positive momentum in new therapy development [Simply Wall St, Yahoo Finance].

Medtronic shows moderate financial concerns with slow growth and modest returns despite strong cash flow generation.

Recent News

• Mental Health Matters at Medtronic. Explore Our Employee Benefits

  Yahoo Finance· 2026-05-18

• Medtronic Neuroscience Appointment Puts Focus On Execution And Growth Risks

  Simply Wall St· 2026-05-19

• Medtronic (MDT) Advances While Market Declines: Some Information for Investors

  Yahoo Finance· 2026-05-18

• Middle East and Africa Wearable Injectors Market Trends and Forecast Report 2026-2035 Featuring Amgen, BD, Biocon, Gerresheimer, Insulet, J&J, Medtronic, Roche, West Pharmaceutical, Ypsomed

  Yahoo Finance· 2026-05-18

• A Once-in-a-Decade Opportunity: 1 Stock to Buy Hand Over Fist and Hold for Years

  Yahoo Finance· 2026-05-17

• Should Medtronic’s AVIM Hypertension Trial Shift Require Action From Medtronic (MDT) Investors?

  Yahoo Finance· 2026-05-14